Stockreport

TSCM U.S. Small Cap Growth Strategy Exited Vaxcyte (PCVX) as Its Infant Trial was Less Than Compelling [Yahoo! Finance]

Vaxcyte, Inc.  (PCVX) 
PDF Small Cap Growth Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here . During the quarter, the fund returned 11.28% (gross) and 11 [Read more]